Recent Headlines
Within Biotechnology
AnaSpec Signs Distribution Agreement with Shanghai Universal Biotech Company
AnaSpec and Shanghai Universal Biotech Company today announced a non-exclusive distributor agreement that will allow Shanghai Universal Biotech Company to distribute AnaSpec’s catalog and custom products throughout China. - November 22, 2008 - AnaSpec, EGT Group
Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot
Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion channel screening. - November 20, 2008 - Nanion Technologies GmbH
Oberon FMR, Inc., Wins the Fourth Annual Dorsey & Whitney Venture Showcase Award, Presented at BioWest 2008
Oberon FMR, Inc., has won the fourth annual Dorsey & Whitney Venture Showcase Award at the 2008 BioWest Conference & Expo in Denver. The announcement is made by Christine Shapard, Interim Executive Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase award was provided by the Dorsey & Whitney law firm and announced at the Colorado Bioscience Association (CBSA) 2008 Awards Dinner. - November 19, 2008 - Colorado BioScience Association
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class... - November 16, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Series of Luminescent and Non-Luminescent Calcium Indicators
AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. - November 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Improved AnaTagTM APC, B-PE and R-PE Labeling Kits
AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits. Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec’s improved... - November 12, 2008 - AnaSpec, EGT Group
Baxa Expands Its Automated Syringe Processing Capabilities
Baxa Corporation is the first to provide colored labels for automated filling of sterile anesthesia syringes, with the addition of colored syringe labels to its Rapid-Fill™ Automated Syringe Filler offering. The system reduces pharmacy overhead for batching activities, while providing the opportunity for more adequate staff allocation and greater inventory control. - November 11, 2008 - Baxa Corporation
Colorado BioScience Association Honors the Best of Colorado’s Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2008 Awards Program. Official presentation of the awards occurs Thursday, November 13, 6:30 to 8:30 p.m., at the CBSA’s annual awards dinner. Governor Bill Ritter, Jr., recipient of one of this year’s Chairman’s Awards, will serve as the Cooley Godward Kronish keynote speaker for this event as the Colorado Bioscience Association celebrates its fifth anniversary. - November 07, 2008 - Colorado BioScience Association
Endometriosis Patients Demand Awareness, Research, and Better Treatments: Sufferers Share What Works and What Does Not
In light of performers Julianne Hough’s and Lacey Schwimmer’s recent disclosure, Endometriosis patients around the world are coming together online to anonymously compare symptoms & related conditions with one another, share treatment reviews, and make research discoveries for future cures. - November 05, 2008 - CureTogether
AnaSpec Introduces Fluorescent Calcium Indicators
Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes... - November 05, 2008 - AnaSpec, EGT Group
National Speakers – Steven Burrill, Guy Kawasaki & T.R. Reid – and Expo with More Than 50 Bioscience Vendors To Attract 700+ at BioWest 2008, Nov. 13 & 14, in Denver
Outstanding national speakers Steven Burrill, Guy Kawasaki and T.R. Reid lead the conference lineup for BioWest 2008, plus 50+ bioscience vendors will introduce their products and services to more than 700 attendees. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - November 01, 2008 - Colorado BioScience Association
Baxa Corporation Launches The Virtual Compounder™
Baxa Corporation announces the launch of The Virtual Compounder – interactive training capability that enhances the functionality of its CriticalPoint USP 797 Sterile Compounding Program. The Virtual Compounder is an innovative series of training lessons that allows users not only to read and memorize materials, but to demonstrate a clear understanding and proficiency in the concepts. - November 01, 2008 - Baxa Corporation
20+ Colorado Bioscience Companies Are Looking to Fill Positions at the 2008 BioWest Conference & Expo’s First Annual Job Fair
The Colorado BioScience Association (CBSA) is hosting a new Bioscience Job Fair the afternoon of November 14, 1:30 to 4 p.m., following the 2008 BioWest Grand Finale Luncheon. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - October 30, 2008 - Colorado BioScience Association
Concierge MedTravel Bridges the Gap for Treatment of Prostate Cancer
Concierge MedTravel, website www.cmedtravel.com, a company bridging the gap for patients diagnosed with prostate cancer with highly advanced medical treatment called Ablatherm® HIFU currently not available in the United States, achieved an important milestone since the inception of Concierge... - October 24, 2008 - Concierge MedTravel
Patients Share Health Data, Become Researchers to Seek Cures for Their Conditions
CureTogether to Demonstrate at Health 2.0 Conference How Some Patients Are Responding to Inadequate Research by Doing It Themselves. - October 23, 2008 - CureTogether
IonSense to Present DART-ET Source for Mass Spectrometry at the Annual Symposium on Chemical and Pharmaceutical Structure Analysis
New technology enables high throughput direct analysis of solid and liquid samples for drug development, food safety, forensics, and medicinal chemistry. - October 23, 2008 - IonSense, Inc.
AnaSpec Introduces New PKD1 & PKD2 Antibodies
Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). - October 23, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyteTM MMP ELISA Kits
MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. - October 18, 2008 - AnaSpec, EGT Group
The 2008 BioWest Conference and Expo Announces National Speaker Lineup, New Job Fair and Popular Venture Showcase Competition
General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2008. More than 700 participants are expected at this year’s event, November 13-14, at the Grand Hyatt in Denver. Noted author of The Art of the Start & business innovation expert Guy Kawasaki leads a prominent lineup of national presenters for BioWest 2008. - October 16, 2008 - Colorado BioScience Association
AnaSpec’s FRET Feature Article Available at Photonics.com
AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. - October 16, 2008 - AnaSpec, EGT Group
BellBrook Labs Announces a Kinase/ATPase Assay That is "2" Sensitive
The Transcreener ADP2 FP Assay is a homogenous fluorescence polarization assay that enables the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. - October 15, 2008 - BellBrook Labs
Finalists Selected for The BioWest 2008 Venture Showcase Competition
New therapeutic small molecule drugs; devices made of unique materials; a highly-sensitive biosensor; advanced DNA immunotherapies; high-protein, low-cost fish food; and, new materials for use in perio-plastic surgical procedures comprise the six finalists in this year’s BioWest Venture Showcase competition. The finalists were selected from a group of 22and will be presenting at the BioWest Venture Showcase on November 13 at the Grand Hyatt-Denver, 1750 Welton. - October 15, 2008 - Colorado BioScience Association
Baxa Corporation Features PadLock®Set Saver at the ANCC National Magnet Conference™
Baxa Corporation is promoting its new PadLock Set Saver at the ANCC National Magnet Conference, October 15-17, in Salt Lake City. An aseptic IV administration set storage solution, PadLock provides a secure seal for the end of the administration set, preventing contamination when the set is not... - October 15, 2008 - Baxa Corporation
Baxa Corporation’s UK Subsidiary Launches ZR® Pre-Filled Saline Flush Syringes
Baxa introduces new line of sterile, pre-filled saline syringes for safe and efficient flushing of IV lines. The ZR syringes meet NHS standards and promote best practice for catheter care. - October 14, 2008 - Baxa Corporation
AnaSpec Introduces Histone GO™ Peptides - Acetylated & Methylated
The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone... - October 11, 2008 - AnaSpec, EGT Group
Pharmacodynamic PAR ELISA Assay
Trevigen introduces a highly sensitive, quantitative and validated assay to measure the effectiveness of PARP inhibitors in cell and tissue lysates for anticancer drug screening. - October 10, 2008 - Trevigen, Inc.
Utilising Cost Reduction Opportunities: Conference on "Optimising Stability Testing" in London
International experts discussed how to realise more efficient stability tests for medicinal products last Thursday and Friday (18 and 19 September) in London. At the two-day "Optimising Stability Testing" conference Dr Sven Oliver Kruse, managing director of Diapharm Analytics GmbH (www.diapharm.com), was one of those explaining how the burden of ongoing stability tests can be reduced with improved study design. - October 01, 2008 - Diapharm
Baxa Corporation Announces USP 797 Course to be Hosted at the STAR Center
Baxa announces it has signed a hosting agreement with the United States Pharmacopeia (USP) for compliance training through the Baxa STAR Center (Skills Training, Academics and Resources) continuing education facility in Englewood, Colorado. Baxa and USP plan to hold 16 sessions of their Compliance Tools for USP 797 course in 2009. - September 30, 2008 - Baxa Corporation
Protein Kinase CK2: New Perspectives of an Old Kinase
Novel, efficient at low micromolar concentrations, and selective CK2 inhibitors [1-7] has been recently designed by OTAVA Ltd., a leading Ukrainian company. To discover new inhibitors, company’s researchers spanned computer-based molecular modeling with chemical synthesis of compounds which were further tested in vitro to investigate their ability to bind to and affect the activity of CK2. The binding modes of inhibitors that target the ATP-binding site of CK2 were also studied. - September 26, 2008 - OTAVA Chemicals Ltd.
Baxa Corp Now Ranks in Top 35 of Largest Private Companies in Denver Area
Englewood-based Baxa Corporation has been named among the top 35 largest private companies in the area by both the Denver Business Journal (DBJ) and ColoradoBiz Magazine. In each publication, Baxa was in the Top 35 for 2008 – moving up five places to #32 in the DBJ (up from #37 in 2007) and #33 in ColoradoBiz (up from #38 in 2007). - September 25, 2008 - Baxa Corporation
NeoCardium Ltd – A New Service Facilitates Regenerative Cardiology Drug Development
A new super specialty regenerative cardiology service launched to support successful clinical development of novel treatments for heart conditions that can be benefited by promoting growth of new tissue to replace, supplement or revascularize the non-functional or under-functioning myocardium. - September 25, 2008 - MRI Limited
TBTA - Click Chemistry Ligand for Cu (I)
Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl)... - September 24, 2008 - AnaSpec, EGT Group
Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry
Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use... - September 22, 2008 - Genomic Nanosystems
Colorado BioScience Association, Colorado Springs Economic Development Corp and CEA Technologies, Inc., Promote the State’s Bioscience Industry AdvaMed MedTech Conference
The Colorado BioScience Association (CBSA), Colorado Springs Economic Development Corporation and CEA Technologies, Inc. are joining forces to promote the State’s burgeoning bioscience industry at the AdvaMed 2008 MedTech Conference in Washington, D.C., September 21-24. Participation in this premier event for medical device manufacturers will showcase Colorado’s CEA Technologies, Inc., a leader in the contract design and manufacture of disposable and reusable electromechanical devices. - September 22, 2008 - Colorado BioScience Association
AnaSpec Celebrates 15 Year Anniversary
Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. - September 21, 2008 - AnaSpec, EGT Group
AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences
AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12(3) Fluorescent Dyes. “BD Biosciences has a tremendous reputation in the industry for innovative products of... - September 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces High Performance Labeled Streptavidins
AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. - September 18, 2008 - AnaSpec, EGT Group
Serendipity Discovers the Holy Grail of Regenerative Cardiology
MetaReports.net releases a breakthrough research report that solves regenerative cardiology companies’ unyielding problem of translating positive pre-clinical data into successful human trials. - September 17, 2008 - MRI Limited
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high... - September 17, 2008 - AnaSpec, EGT Group
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex... - September 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Kinase Substrates as GO™ Peptides
Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of... - September 11, 2008 - AnaSpec, EGT Group
Recombinant MOG Proteins - New
Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat. These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were... - September 10, 2008 - AnaSpec, EGT Group
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2008 BioWest Conference & Expo
The organizers of BioWest 2008 are again looking for the best bioscience start-ups in the region as candidates for the $10,000 Dorsey & Whitney Venture Showcase Award. Six companies will be chosen to present at the showcase on Thursday, November 13, 2008, and will be judged by a panel of national venture capitalists. Deadline for entry is Monday, October 1. - September 06, 2008 - Colorado BioScience Association
Accugenix Announces Release of Updated Bacterial Sequence Library: 283 New Entries Continue to Grow Lab’s Impressive DNA Sequence Database
Accugenix, the leader in genetic microbial identification and characterization services, announced today the addition of 283 new species to its extensive Bacterial Library, bringing the total number of unique bacterial DNA sequences on file to over 2400. With this library release, Accugenix continues to provide the pharmaceutical, biotech, medical device, and other manufacturers with rapid, accurate and cost-effective resources to maintain a sterile, safe and compliant environment for consumers. - September 04, 2008 - Accugenix, Inc.
Anavex Completes Successful Preclinical Studies on Lead Alzheimer's Drug Candidate
Anavex completes successful preclinical studies on Anavex 2-73, a novel sigma-1 receptor agonist for the treatment of Alzheimer's disease. - September 04, 2008 - Anavex Life Sciences Corp.
AnaSpec Peptides Used in Latest Alzheimer’s Research Findings by VU University Medical Centre and Lund University
At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.” The authors of the study... - August 31, 2008 - AnaSpec, EGT Group
New Anti-GHSR Antibodies from AnaSpec
AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence. GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands... - August 30, 2008 - AnaSpec, EGT Group
AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases
AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent # 5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.” "We are pleased to... - August 29, 2008 - AnaSpec, EGT Group
Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
Baxa Corporation announces its ranking in the second annual list of top 5,000 fastest-growing private businesses in the US; proof that the economy is not slowing its growth. The company has grown steadily since its founding in 1975 and currently employs more than 450 associates through its Colorado headquarters and UK subsidiary offices. - August 28, 2008 - Baxa Corporation
Cultrex® Mouse Laminin I Now Qualified “PathClear®”
Trevigen adds mouse Laminin I to PathClear® designated products for research involving cancer cell characterization and behavior. - August 22, 2008 - Trevigen, Inc.